Halozyme Therapeutics shares owned by Ingalls & Snyder
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ingalls & Snyder
from 13F filings
Historical chart of Ingalls & Snyder investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Ingalls & Snyder
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $397k | 5.4k | 73.36 |
| 2020-12-31 | $349k | 8.2k | 42.67 |
| 2020-09-30 | $333k | 13k | 26.31 |
| 2020-06-30 | $339k | 13k | 26.79 |